Boehringer Ingelheim International GmbH
Boehringer Ingelheim welcomes you to ARVO 2022
At Boehringer Ingelheim, we recognize that vision is a vital connection to life that must be preserved and protected.
We aim to drive excellence through connections with other specialists in the field and patients, bringing years of experience to areas of high unmet need and closing important gaps in knowledge across retinal diseases.
From early diagnosis and intervention to establishing new medicines for currently untreatable diseases, providing treatments with extended durability, and reducing treatment burden, Boehringer Ingelheim is committed to taking an active, comprehensive approach to retinal disease.
Join Boehringer Ingelheim at ARVO 2022, as we dive deeper on a journey of discovery to improve outcomes for our patients and usher in a new wave of innovation in the field of retinal health.